XML 15 R4.htm IDEA: XBRL DOCUMENT v3.25.2
Consolidated Statements of Profit and Loss - USD ($)
 3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Income Statement [Abstract]    
Net Sales $ 2,290,282 $ 742,991
Cost of Sales 1,150,516 357,123
Gross Profit 1,139,766 385,868
Operating Expenses:    
Sales & Marketing 617,699 136,610
General & Administrative 900,034 356,265
Depreciation & Amortization 237,011 185,316
Payroll Expenses 840,861 208,455
Research and Development Cost 116,686 47,691
Total Operating Expenses 2,712,291 934,337
Operating Income (Loss) (1,572,525) (548,469)
Other Income (Expenses):    
Other Income 1,451 30
Other Expenses (109,649) 2,730
Total Other Income (Loss) (108,198) 2,760
Income (Loss) Before Tax (1,680,723) (545,709)
Tax Provision
Net Income (Loss) $ (1,680,723) $ (545,709)
Basic $ (0.12) $ (0.06)
Fully diluted $ (0.12) $ (0.06)
Weighted average of shares oustanding, basic 14,271,581 9,234,650
Weighted average of shares oustanding, diluted 14,271,581 9,234,650